Failure of Guideline-based Anticoagulation in a Patient with Mitral Prosthetic Valve and Recurrent Thromboembolism
Prosthetic valve (PV)-related thromboembolism is a rare but serious complication of implanted mechanical valves. There is not a design that has yet achieved mechanical perfection; therefore, using these mechanical valves is not free of mortality and morbidity. Some of the complications of using such...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Society of Echocardiography 2008-03, Vol.21 (3), p.296.e1-296.e3 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 296.e3 |
|---|---|
| container_issue | 3 |
| container_start_page | 296.e1 |
| container_title | Journal of the American Society of Echocardiography |
| container_volume | 21 |
| creator | Mutlu, Halil, MD Yerlioglu, Mustafa E., MD Levy, William K., MD |
| description | Prosthetic valve (PV)-related thromboembolism is a rare but serious complication of implanted mechanical valves. There is not a design that has yet achieved mechanical perfection; therefore, using these mechanical valves is not free of mortality and morbidity. Some of the complications of using such valves include PV thrombosis, systemic embolization, bleeding, endocarditis, perivalvular leak, and structural valve failure. These valves are thrombogenic, and their use requires anticoagulation postoperatively to prevent systemic embolization and PV thrombosis. This intervention also carries the risk of bleeding, which can be detrimental for a subset of patients, especially elderly, pregnant, and those with other systemic comorbidities. In this case we present a patient with recurrent thromboembolic events and a nonobstructing St. Jude mitral PV thrombosis despite vigorous anticoagulation with Coumadin (Bristol-Myers Squibb Co., Princeton, NJ) and aspirin. |
| doi_str_mv | 10.1016/j.echo.2007.06.015 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70355521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0894731707004890</els_id><sourcerecordid>70355521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-5884f4aad79a301a5b5ddbca01cc1f0ff57d221b950865e2597990fb668675bf3</originalsourceid><addsrcrecordid>eNp9kU1r3DAQhkVpaDZp_0APRafe7I5sy7KgFEJoPiChoU17FbI07morW6lkJ-TfV2YXCj30IEaH5x2Y5yXkLYOSAWs_7Eo021BWAKKEtgTGX5ANAymKVkj-kmygk00haiaOyUlKOwDgHcArcsxE2zFRVxsSL7TzS0QaBnq5OIveTVj0OqGlZ9PsTNA_F69nFybqJqrpXf7jNNMnN2_prZuj9vQuhjRvMdP0h_aPSPVk6Vc0S4wrer-NYewD5uddGl-To0H7hG8O85R8v_h8f35V3Hy5vD4_uylMA3IueNc1Q6O1FVLXwDTvubW90cCMYQMMAxe2qlgvOXQtx4pLISUMfdt2reD9UJ-S9_u9DzH8XjDNanTJoPd6wrAkJaDmnFcsg9UeNPmOFHFQD9GNOj4rBmo1rXZqNa1W0wpalU3n0LvD9qUf0f6NHNRm4OMewHzjo8OoksnmDFoX0czKBvf__Z_-iZtcjTPa_8JnTLuwxCnbU0ylSoH6tna9Vg0CoOkk1H8AtGylsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70355521</pqid></control><display><type>article</type><title>Failure of Guideline-based Anticoagulation in a Patient with Mitral Prosthetic Valve and Recurrent Thromboembolism</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mutlu, Halil, MD ; Yerlioglu, Mustafa E., MD ; Levy, William K., MD</creator><creatorcontrib>Mutlu, Halil, MD ; Yerlioglu, Mustafa E., MD ; Levy, William K., MD</creatorcontrib><description>Prosthetic valve (PV)-related thromboembolism is a rare but serious complication of implanted mechanical valves. There is not a design that has yet achieved mechanical perfection; therefore, using these mechanical valves is not free of mortality and morbidity. Some of the complications of using such valves include PV thrombosis, systemic embolization, bleeding, endocarditis, perivalvular leak, and structural valve failure. These valves are thrombogenic, and their use requires anticoagulation postoperatively to prevent systemic embolization and PV thrombosis. This intervention also carries the risk of bleeding, which can be detrimental for a subset of patients, especially elderly, pregnant, and those with other systemic comorbidities. In this case we present a patient with recurrent thromboembolic events and a nonobstructing St. Jude mitral PV thrombosis despite vigorous anticoagulation with Coumadin (Bristol-Myers Squibb Co., Princeton, NJ) and aspirin.</description><identifier>ISSN: 0894-7317</identifier><identifier>EISSN: 1097-6795</identifier><identifier>DOI: 10.1016/j.echo.2007.06.015</identifier><identifier>PMID: 17681732</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Aged ; Anticoagulants - administration & dosage ; Cardiovascular ; Heart Valve Prosthesis - adverse effects ; Humans ; Male ; Mitral Valve Insufficiency - surgery ; Practice Guidelines as Topic ; Prosthesis Failure ; Secondary Prevention ; Thromboembolism - etiology ; Thromboembolism - prevention & control ; Treatment Failure</subject><ispartof>Journal of the American Society of Echocardiography, 2008-03, Vol.21 (3), p.296.e1-296.e3</ispartof><rights>American Society of Echocardiography</rights><rights>2008 American Society of Echocardiography</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-5884f4aad79a301a5b5ddbca01cc1f0ff57d221b950865e2597990fb668675bf3</citedby><cites>FETCH-LOGICAL-c409t-5884f4aad79a301a5b5ddbca01cc1f0ff57d221b950865e2597990fb668675bf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0894731707004890$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17681732$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mutlu, Halil, MD</creatorcontrib><creatorcontrib>Yerlioglu, Mustafa E., MD</creatorcontrib><creatorcontrib>Levy, William K., MD</creatorcontrib><title>Failure of Guideline-based Anticoagulation in a Patient with Mitral Prosthetic Valve and Recurrent Thromboembolism</title><title>Journal of the American Society of Echocardiography</title><addtitle>J Am Soc Echocardiogr</addtitle><description>Prosthetic valve (PV)-related thromboembolism is a rare but serious complication of implanted mechanical valves. There is not a design that has yet achieved mechanical perfection; therefore, using these mechanical valves is not free of mortality and morbidity. Some of the complications of using such valves include PV thrombosis, systemic embolization, bleeding, endocarditis, perivalvular leak, and structural valve failure. These valves are thrombogenic, and their use requires anticoagulation postoperatively to prevent systemic embolization and PV thrombosis. This intervention also carries the risk of bleeding, which can be detrimental for a subset of patients, especially elderly, pregnant, and those with other systemic comorbidities. In this case we present a patient with recurrent thromboembolic events and a nonobstructing St. Jude mitral PV thrombosis despite vigorous anticoagulation with Coumadin (Bristol-Myers Squibb Co., Princeton, NJ) and aspirin.</description><subject>Aged</subject><subject>Anticoagulants - administration & dosage</subject><subject>Cardiovascular</subject><subject>Heart Valve Prosthesis - adverse effects</subject><subject>Humans</subject><subject>Male</subject><subject>Mitral Valve Insufficiency - surgery</subject><subject>Practice Guidelines as Topic</subject><subject>Prosthesis Failure</subject><subject>Secondary Prevention</subject><subject>Thromboembolism - etiology</subject><subject>Thromboembolism - prevention & control</subject><subject>Treatment Failure</subject><issn>0894-7317</issn><issn>1097-6795</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1r3DAQhkVpaDZp_0APRafe7I5sy7KgFEJoPiChoU17FbI07morW6lkJ-TfV2YXCj30IEaH5x2Y5yXkLYOSAWs_7Eo021BWAKKEtgTGX5ANAymKVkj-kmygk00haiaOyUlKOwDgHcArcsxE2zFRVxsSL7TzS0QaBnq5OIveTVj0OqGlZ9PsTNA_F69nFybqJqrpXf7jNNMnN2_prZuj9vQuhjRvMdP0h_aPSPVk6Vc0S4wrer-NYewD5uddGl-To0H7hG8O85R8v_h8f35V3Hy5vD4_uylMA3IueNc1Q6O1FVLXwDTvubW90cCMYQMMAxe2qlgvOXQtx4pLISUMfdt2reD9UJ-S9_u9DzH8XjDNanTJoPd6wrAkJaDmnFcsg9UeNPmOFHFQD9GNOj4rBmo1rXZqNa1W0wpalU3n0LvD9qUf0f6NHNRm4OMewHzjo8OoksnmDFoX0czKBvf__Z_-iZtcjTPa_8JnTLuwxCnbU0ylSoH6tna9Vg0CoOkk1H8AtGylsQ</recordid><startdate>20080301</startdate><enddate>20080301</enddate><creator>Mutlu, Halil, MD</creator><creator>Yerlioglu, Mustafa E., MD</creator><creator>Levy, William K., MD</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080301</creationdate><title>Failure of Guideline-based Anticoagulation in a Patient with Mitral Prosthetic Valve and Recurrent Thromboembolism</title><author>Mutlu, Halil, MD ; Yerlioglu, Mustafa E., MD ; Levy, William K., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-5884f4aad79a301a5b5ddbca01cc1f0ff57d221b950865e2597990fb668675bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>Anticoagulants - administration & dosage</topic><topic>Cardiovascular</topic><topic>Heart Valve Prosthesis - adverse effects</topic><topic>Humans</topic><topic>Male</topic><topic>Mitral Valve Insufficiency - surgery</topic><topic>Practice Guidelines as Topic</topic><topic>Prosthesis Failure</topic><topic>Secondary Prevention</topic><topic>Thromboembolism - etiology</topic><topic>Thromboembolism - prevention & control</topic><topic>Treatment Failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mutlu, Halil, MD</creatorcontrib><creatorcontrib>Yerlioglu, Mustafa E., MD</creatorcontrib><creatorcontrib>Levy, William K., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Society of Echocardiography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mutlu, Halil, MD</au><au>Yerlioglu, Mustafa E., MD</au><au>Levy, William K., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Failure of Guideline-based Anticoagulation in a Patient with Mitral Prosthetic Valve and Recurrent Thromboembolism</atitle><jtitle>Journal of the American Society of Echocardiography</jtitle><addtitle>J Am Soc Echocardiogr</addtitle><date>2008-03-01</date><risdate>2008</risdate><volume>21</volume><issue>3</issue><spage>296.e1</spage><epage>296.e3</epage><pages>296.e1-296.e3</pages><issn>0894-7317</issn><eissn>1097-6795</eissn><abstract>Prosthetic valve (PV)-related thromboembolism is a rare but serious complication of implanted mechanical valves. There is not a design that has yet achieved mechanical perfection; therefore, using these mechanical valves is not free of mortality and morbidity. Some of the complications of using such valves include PV thrombosis, systemic embolization, bleeding, endocarditis, perivalvular leak, and structural valve failure. These valves are thrombogenic, and their use requires anticoagulation postoperatively to prevent systemic embolization and PV thrombosis. This intervention also carries the risk of bleeding, which can be detrimental for a subset of patients, especially elderly, pregnant, and those with other systemic comorbidities. In this case we present a patient with recurrent thromboembolic events and a nonobstructing St. Jude mitral PV thrombosis despite vigorous anticoagulation with Coumadin (Bristol-Myers Squibb Co., Princeton, NJ) and aspirin.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>17681732</pmid><doi>10.1016/j.echo.2007.06.015</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0894-7317 |
| ispartof | Journal of the American Society of Echocardiography, 2008-03, Vol.21 (3), p.296.e1-296.e3 |
| issn | 0894-7317 1097-6795 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70355521 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Aged Anticoagulants - administration & dosage Cardiovascular Heart Valve Prosthesis - adverse effects Humans Male Mitral Valve Insufficiency - surgery Practice Guidelines as Topic Prosthesis Failure Secondary Prevention Thromboembolism - etiology Thromboembolism - prevention & control Treatment Failure |
| title | Failure of Guideline-based Anticoagulation in a Patient with Mitral Prosthetic Valve and Recurrent Thromboembolism |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T18%3A26%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Failure%20of%20Guideline-based%20Anticoagulation%20in%20a%20Patient%20with%20Mitral%20Prosthetic%20Valve%20and%20Recurrent%20Thromboembolism&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Echocardiography&rft.au=Mutlu,%20Halil,%20MD&rft.date=2008-03-01&rft.volume=21&rft.issue=3&rft.spage=296.e1&rft.epage=296.e3&rft.pages=296.e1-296.e3&rft.issn=0894-7317&rft.eissn=1097-6795&rft_id=info:doi/10.1016/j.echo.2007.06.015&rft_dat=%3Cproquest_cross%3E70355521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70355521&rft_id=info:pmid/17681732&rft_els_id=1_s2_0_S0894731707004890&rfr_iscdi=true |